Insider screener

Period: 12 months Plan: Not on a plan × + Add filter Clear all
Saved screens

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

When

Period

How far back the list reaches. Filings arrive days after the trade, so the newest rows always lag a little.

36,701 decisions over 12 months
Who

Role

The position the person holds at the company, read from the title on the filing. A chief executive who is also a director counts as the chief executive.

36,701 decisions over 12 months
The trade

Type of trade

Purchases, sales, or cluster buys: companies where 3 or more insiders bought within 30 days. The number beside each is what that choice would give.

36,701 decisions over 12 months
The trade

Minimum amount

Hides rows under this value. The amount is the shares traded times the price on the filing.

36,701 decisions over 12 months
The trade

Plan

  • Discretionary: they chose to sell that week.
  • Scheduled: a 10b5-1 plan fixed the sale months in advance, so the timing says nothing about what they knew.
  • Not stated: filed before the SEC added the box in April 2023, which is most of the older half of this database.
36,701 decisions over 12 months Remove this filter
The trade

Share of their own holding

How much of what they already held the trade moved. Selling a tenth of a stake is not the same act as selling all of it.

At least
36,701 decisions over 12 months
Ownership

What the chief executive holds

The value of the chief executive’s stock measured against base salary. The salary comes from the company’s own proxy. Companies with no figure are in neither direction.

36,701 decisions over 12 months
Stock
Insider
Type ?
Why it stands out
16 Mar 2026
Mark W Sawicki Chief Scientific Officer
Sold at will
$25.88K 3,235 at 8.00
3.0%
Not planned
16 Mar 2026
Angela A Korch EVP & Chief Financial Officer
Bought
$25.05K 190 at 131.85
3.6%
16 Mar 2026
John D Duke Chief Executive Officer
Bought
$25.05K 5,000 at 5.01
5.0%
First buy on file
16 Mar 2026
Mark T Frost Chief Financial Officer
Bought
$25.00K 5,000 at 5.00
40.0%
First buy on file
16 Mar 2026
Laura Lee Sandler Chief Operating Officer
Sold at will
$24.78K 600 at 41.30
0.3%
Not planned
16 Mar 2026
Bought
$24.60K 30,000 at 0.82
34.4%
Largest buy in 3 yrs
16 Mar 2026
Eugene Nonko Director
Sold at will
$24.45K 2,444 at 10.00
0.2%
Not planned
16 Mar 2026
Samantha L. Sloan EVP, Corporate Affairs
Sold at will
$24.10K 120 at 200.80
6.7%
Not planned
16 Mar 2026
Andrew David Oddie Chief International Officer
Sold at will
$23.19K 6,250 at 3.71
8.3%
Not planned
16 Mar 2026
Michael J Mardy Director
Bought
$23.00K 1,099 at 20.93
6.5%
16 Mar 2026
Bought
$23.00K 1,300 at 17.69
0.6%
16 Mar 2026
John Ritota Director
Sold at will
$22.94K 4,740 at 4.84
9.8%
Not planned
16 Mar 2026
Andrea Renee Bortner See Remarks
Sold at will
$22.45K 3,705 at 6.06
4.5%
Not planned
16 Mar 2026
Peggy Scott Director
Bought
$22.27K 1,064 at 20.93
4.4%
16 Mar 2026
Robert Stefanovich Chief Financial Officer
Sold at will
$21.94K 2,743 at 8.00
1.0%
Not planned
16 Mar 2026
Deborah Ann Gero Director
Bought
$21.56K 2,000 at 10.78
8.9%
16 Mar 2026
Luke D Thompson EVP, GC and Secretary
Sold at will
$20.76K 3,425 at 6.06
3.6%
Not planned
16 Mar 2026
Charles W Henry Director
Bought
$20.70K 989 at 20.93
1.3%
16 Mar 2026
Ramzi Ammari Sr.VP Corp Planning & Strategy
Sold at will
$20.43K 4,916 at 4.16
11.5%
Not planned
16 Mar 2026
Chan Galbato Director
Bought
$20.13K 962 at 20.93
42.5%
Largest buy in 3 yrs
16 Mar 2026
Jay S. Duker President and CEO · indirect
Bought
$19.72K 1,500 at 13.15
1.5%
First buy on file
16 Mar 2026
Joseph K Schachle Chief Operating Officer
Sold at will
$19.53K 3,719 at 5.25
1.2%
Not planned
16 Mar 2026
Everett Rand Sutherland Chief Executive Officer
Sold at will
$19.44K 2,093 at 9.29
2.8%
Not planned
16 Mar 2026
Ashwath Jayagopal Chief Scientific & Dev. Ofc.
Sold at will
$19.05K 3,719 at 5.12
0.7%
Not planned
16 Mar 2026
Larry G Swets Jr Director
Bought
$19.00K 50,000 at 0.38
33.3%
+33% of stake
16 Mar 2026
Bought
$17.06K 5,486 at 3.11
1.8%
16 Mar 2026
Jill G. Mcconnell Chief Financial Officer also filed by Mark A. Morais
Sold at will
$16.63K 1,804 at 9.22
2.4%
Not planned
16 Mar 2026
Christopher C. Swenson Chief Legal Officer
Sold at will
$16.53K 18,366 at 0.90
0.9%
Not planned
16 Mar 2026
Arjun Agarwal Senior Vice President, Finance
Sold at will
$16.31K 395 at 41.30
2.1%
Not planned
16 Mar 2026
Edward J Zecchini See Remarks
Sold at will
$16.11K 2,014 at 8.00
1.8%
Not planned
16 Mar 2026
Haitao Cui Executive Vice President
Sold at will
$15.71K 3,888 at 4.04
2.8%
Not planned
16 Mar 2026
Jerome Wong Chief Financial Officer · indirect also filed by Jason C Jones
Bought
$15.50K 1,308 at 11.85
45.5%
First buy on file
16 Mar 2026
Rabourn Amy Zaremba Head of Fin. Quality Assurance
Sold at will
$14.77K 2,816 at 5.25
1.5%
Not planned
16 Mar 2026
Robert T. Ladd President and CEO
Bought
$14.37K 1,700 at 8.45
0.3%
16 Mar 2026
Heather C Getz Director
Bought
$13.97K 20,000 at 0.70
17.9%
16 Mar 2026
Robert George Culp IV President & CEO
Bought
$13.81K 4,383 at 3.15
3.9%
16 Mar 2026
Husnal Shah Chief Product Officer
Sold at will
$13.60K 3,651 at 3.73
17.9%
Not planned
16 Mar 2026
Sarah A. Mussetter Chief Legal Officer
Sold at will
$12.96K 4,037 at 3.21
3.5%
Not planned
16 Mar 2026
Benjamin Machinas Beneski SVP, Chief Technical Officer
Sold at will
$11.94K 4,835 at 2.47
2.4%
Not planned
16 Mar 2026
Ronald E. Estes Director
Bought
$11.33K 800 at 14.16
2.0%
16 Mar 2026
Melvin L Keating Director
Bought 2×
$10.94K 160 at 68.38
0.5%
16 Mar 2026
Sold at will
$10.59K 2,832 at 3.74
4.6%
Not planned
16 Mar 2026
Greg Foley Chief Executive Officer
Sold at will
$10.28K 2,584 at 3.98
13.4%
Not planned
16 Mar 2026
Glenbrook Capital Management 10% owner · indirect
Bought
$9.39K 5,060 at 1.86
0.6%
16 Mar 2026
Mary Jo S. Herseth Director · indirect
Bought
$9.25K 300 at 30.83
1.6%
16 Mar 2026
Ivo James Cavoli Director
Bought
$8.92K 2,315 at 3.86
4.6%
16 Mar 2026
Gil Todd Silva Director
Bought
$8.71K 2,000 at 4.36
opened
First buy on file
16 Mar 2026
Aaron Deykin Chief Medical Officer
Sold at will
$8.31K 894 at 9.29
2.7%
Not planned
Showing 22,401–22,450 of 36,701. ← Newer Page 449 of 735 Older →